skip to content »

Measuring brand power validating a model for optimizing brand equity

measuring brand power validating a model for optimizing brand equity-41

More specifically, we have developed and evaluated a system that has two parts, a tutor and a meta-tutor.The tutor is a simple step-based tutoring system that can give correct/incorrect feedback on student’s steps and can demonstrate steps for students when asked.

measuring brand power validating a model for optimizing brand equity-6

Erik Phillips, US Director of Sales & Business Development, Auto Coding Systems Charles Breem, Independent Advisor, FSMA Consulting Services for EAS Consulting Group Sam Vail, US Director of Operations, Auto Coding Systems Michael Murphy, MD, Ph D, Chief Medical and Scientific Officer Josie Measures, Vice President Biostatistical Operations Lorna Graham, BSc, MSc, Associate Director, Project Management, Evidence Barbara Zupancic, Director, Global Patient Recruitment and Retention - This webinar will discuss the findings from a commissioned study conducted by Forrester Consulting on behalf of Attivio surveying 112 life sciences experts involved with data analytics and visualization regarding current challenges such as too many data sets, unstandardized formats, multiple data sources (many outside the firewall), and lack of business-friendly analytics - The speakes will discuss how to prepare your organization for excellence related to the increased requirements in vendor management, operational data collection and reporting, and risk-based monitoring Victoria Moore, FCCA, Executive Director, Global Business Finance, INC Research Shaun Williams, Director, Investigator Payments, INC Research Marcus Thornton, Principal, Platform Adoption, Medidata Nina Pruitt, Senior Director, Global Product Marketing, Medidata - Discussion topics include risk factors for disease progression, the detection, assessment and monitoring of DILI in NASH patients, and the strategic framework of applying a seamless adaptive design in a NASH development program Arun Sanyal, MD, Professor of Medicine and Chairman of Gastroenterology Division, Virginia Commonwealth University School of Medicine Claudia Filozof, MD, Ph D Executive, Medical Director in CVM/ER Therapeutic Area, Covance Arie Regev, MD, Head of the Safety Advisory Hub, Eli Lilly and Company Tammy Mc Iver, MSc, CStat, Senior Manager, Biostatistics and Statistical Programming, Covance - Viewers will learn how implementation, evolution and change management are critical for a successful remote monitoring program.However, when the meta-tutor and tutor were turned off, students tended to revert to shallow modelling.Thus, the next stage of the research is to add an affective agent that will try to persuade students to persist in using the taught strategies even when the meta-tutoring and tutoring have ceased.We conducted three experiments to test the effectiveness of the meta-tutor.The results indicate that students who studied with meta-tutor did indeed engage in more deep modelling practices.ABSTRACT: Lesson plans are a potentially powerful means to facilitate teachers’ use of technology in the classroom.

This study investigated which supplementary information is preferred by teachers when integrating a new technology into the classroom.

ABSTRACT: The purpose of this study is to investigate and compare students’ collaborative inquiry learning behaviors and their behavior patterns in an augmented reality (AR) simulation system and a traditional 2D simulation system.

Their inquiry and discussion processes were analyzed by content analysis and lag sequential analysis (LSA).

Most pre-service teachers, by contrast, were future-oriented and preferred support that would help increase their proficiency rather than consolidate their existing knowledge base.

ABSTRACT: Modelling is an important skill to acquire, but it is not an easy one for students to learn.

- This webinar will explore the development process, the changing regulatory environment, and the device approval pathways to help sponsors optimize the likelihood of regulatory and commercial success - In this webinar, the presenter will consider issues associated with the application of cognitive tests to guide decision making about the safety and efficacy of drugs in both the chronic and acute stages of schizophrenia - In this webinar, the speaker will examine the requirements listed in MEDDEV 2.7/1 revision.